Loading...
01/09 08:43
Loading...
Voyager Therapeutics Inc (VYGR) is set to release its earnings performance on 03/11 04:00:00 in After Hours trading. Consensus forecasts predict a revenue of 16.58M and an earnings per share (EPS) of -0.34 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings call revealed missed EPS expectations, indicating financial instability. Despite promising partnerships and clinical milestones, setbacks in gene therapy and reliance on partnerships pose risks. Regulatory challenges and market competition further add to uncertainties. The Q&A highlighted management's evasive responses and potential risks in clinical trials. Overall, the negative sentiment from financial results and uncertainties outweighs the positives, suggesting a negative stock price reaction.
The earnings call highlights strong financial health with $332 million cash and $8.2 billion in potential milestone payments. Key partnerships and promising gene therapy developments indicate positive business momentum. The Q&A section reveals optimism about upcoming milestones and external partnerships, despite some management ambiguity. Overall, the financial outlook and strategic advancements suggest a positive stock price movement.
The earnings call highlights strong financials with a $345 million cash position, robust pipeline development, and valuable partnerships with Novartis and Neurocrine. Despite regulatory and market risks, the company's strategic focus on gene therapy and tau-targeting therapies suggests potential long-term value creation. The Q&A section indicates positive sentiment towards the company's innovative approaches, although there are uncertainties in timing for certain milestones. Overall, the strategic initiatives and partnerships are likely to drive a positive stock price movement in the short term.
Voyager Therapeutics Inc (VYGR) is scheduled to release its FY2024Q4 earnings report onMar 11, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 16.58M in revenue and an EPS of -0.34 for Voyager Therapeutics Inc's FY2024Q4.
Intellectia's exclusive AI algorithms forecast a forVoyager Therapeutics Inc's FY2024Q4 earnings, with a prediction date of Mar 11, 2025. Voyager Therapeutics Inc
Leverage Intellectia's AI forecast to position trades ahead of theMar 11, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!
